Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexei N Plotnikov

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Circulation|September 15, 2005
Repolarization gradients in the canine left ventricle before and after induction of short-term cardiac memoryMichiel J Janse, Eugene A Sosunov, Ruben Coronel, et al.
Circulation|January 22, 2004
Biological pacemaker implanted in canine left bundle branch provides ventricular escape rhythms that have physiologically acceptable ratesAlexei N Plotnikov, Eugene A Sosunov, Jihong Qu, et al.
Circulation|July 25, 2007
Xenografted adult human mesenchymal stem cells provide a platform for sustained biological pacemaker function in canine heartAlexei N Plotnikov, Iryna Shlapakova, Matthias J Szabolcs, et al.
Cardiovascular Research|August 2, 2005
The cAMP response element binding protein modulates expression of the transient outward current: implications for cardiac memoryKornelis W Patberg, Maria N Obreztchikova, Sarah F Giardina, et al.
Circulation|August 23, 2006
Wild-type and mutant HCN channels in a tandem biological-electronic cardiac pacemakerAnnalisa Bucchi, Alexei N Plotnikov, Iryna Shlapakova, et al.
JAMA Cardiology|May 30, 2019
P2Y12 Inhibitor Switching in Response to Routine Notification of CYP2C19 Clopidogrel Metabolizer Status Following Acute Coronary SyndromesThomas J Povsic, E Magnus Ohman, Matthew T Roe, et al.
The New England Journal of Medicine|November 15, 2011
Rivaroxaban in patients with a recent acute coronary syndromeJessica L Mega, Eugene Braunwald, Stephen D Wiviott, et al.
American Heart Journal|February 22, 2025
Oral factor xia inhibitor milvexian after a recent acute coronary syndrome: Rationale and design of the phase 3 (Librexia ACS)C Michael Gibson, M Cecilia Bahit, Roxana Mehran, et al.
American Heart Journal|August 30, 2024
Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and designSneha S Jain, Kenneth W Mahaffey, Karen S Pieper, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Circulation|September 15, 2005
Repolarization gradients in the canine left ventricle before and after induction of short-term cardiac memoryMichiel J Janse, Eugene A Sosunov, Ruben Coronel, et al.
Circulation|January 22, 2004
Biological pacemaker implanted in canine left bundle branch provides ventricular escape rhythms that have physiologically acceptable ratesAlexei N Plotnikov, Eugene A Sosunov, Jihong Qu, et al.
Circulation|July 25, 2007
Xenografted adult human mesenchymal stem cells provide a platform for sustained biological pacemaker function in canine heartAlexei N Plotnikov, Iryna Shlapakova, Matthias J Szabolcs, et al.
Cardiovascular Research|August 2, 2005
The cAMP response element binding protein modulates expression of the transient outward current: implications for cardiac memoryKornelis W Patberg, Maria N Obreztchikova, Sarah F Giardina, et al.
Circulation|August 23, 2006
Wild-type and mutant HCN channels in a tandem biological-electronic cardiac pacemakerAnnalisa Bucchi, Alexei N Plotnikov, Iryna Shlapakova, et al.
JAMA Cardiology|May 30, 2019
P2Y12 Inhibitor Switching in Response to Routine Notification of CYP2C19 Clopidogrel Metabolizer Status Following Acute Coronary SyndromesThomas J Povsic, E Magnus Ohman, Matthew T Roe, et al.
The New England Journal of Medicine|November 15, 2011
Rivaroxaban in patients with a recent acute coronary syndromeJessica L Mega, Eugene Braunwald, Stephen D Wiviott, et al.
American Heart Journal|February 22, 2025
Oral factor xia inhibitor milvexian after a recent acute coronary syndrome: Rationale and design of the phase 3 (Librexia ACS)C Michael Gibson, M Cecilia Bahit, Roxana Mehran, et al.
American Heart Journal|August 30, 2024
Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and designSneha S Jain, Kenneth W Mahaffey, Karen S Pieper, et al.
Pageof 3